Open-Angle Glaucoma - Epidemiology Forecast to 2032

January 2022 | 60 pages | ID: O7E53876DC3EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Open-Angle Glaucoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Open-Angle Glaucoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Open-Angle Glaucoma Understanding

The DelveInsight Open-Angle Glaucoma epidemiology report gives a thorough understanding of the Open-Angle Glaucoma by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Open-Angle Glaucoma in the US, Europe, and Japan. The report covers the detailed information of the Open-Angle Glaucoma epidemiology scenario in seven major countries (US, EU5, and Japan).

Open-Angle Glaucoma Epidemiology Perspective by DelveInsight

The Open-Angle Glaucoma epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Open-Angle Glaucoma epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Open-Angle Glaucoma epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Open-Angle Glaucoma Detailed Epidemiology Segmentation

The Open-Angle Glaucoma epidemiology covered in the report provides historical as well as forecasted Open-Angle Glaucoma epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Open-Angle Glaucoma report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Open-Angle Glaucoma report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Open-Angle Glaucoma Epidemiology Report and Model provide an overview of the global trends of Open-Angle Glaucoma in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Open-Angle Glaucoma in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Open-Angle Glaucoma
• The report provides the segmentation of the Open-Angle Glaucoma epidemiology

Report Highlights

• 11-year Forecast of Open-Angle Glaucoma epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Open-Angle Glaucoma
• Cases of Open-Angle Glaucoma by Mutation Types
• Open-Angle Glaucoma Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Open-Angle Glaucoma?
• What are the key findings pertaining to the Open-Angle Glaucoma epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Open-Angle Glaucoma across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Open-Angle Glaucoma?
• What are the currently available treatments of Open-Angle Glaucoma?

Reasons to buy

The Open-Angle Glaucoma Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Open-Angle Glaucoma market
• Quantify patient populations in the global Open-Angle Glaucoma market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Open-Angle Glaucoma therapeutics in each of the markets covered
• Understand the magnitude of Open-Angle Glaucoma population by its epidemiology
• The Open-Angle Glaucoma Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF OPEN-ANGLE GLAUCOMA

3. OPEN-ANGLE GLAUCOMA: DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Open-Angle Glaucoma Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Open-Angle Glaucoma Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Open-Angle Glaucoma Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Open-Angle Glaucoma Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Open-Angle Glaucoma Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Open-Angle Glaucoma Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Open-Angle Glaucoma Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Open-Angle Glaucoma Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Open-Angle Glaucoma Treatment and Management
6.2. Open-Angle Glaucoma Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Open-Angle Glaucoma Epidemiology in 7MM (2019-2032)
Table 2: Open-Angle Glaucoma Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Open-Angle Glaucoma Epidemiology in the United States (2019-2032)
Table 4: Open-Angle Glaucoma Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Open-Angle Glaucoma Epidemiology in Germany (2019-2032)
Table 6: Open-Angle Glaucoma Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Open-Angle Glaucoma Epidemiology in France (2019-2032)
Table 8: Open-Angle Glaucoma Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Open-Angle Glaucoma Epidemiology in Italy (2019-2032)
Table 10: Open-Angle Glaucoma Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Open-Angle Glaucoma Epidemiology in Spain (2019-2032)
Table 12: Open-Angle Glaucoma Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Open-Angle Glaucoma Epidemiology in the United Kingdom (2019-2032)
Table 14: Open-Angle Glaucoma Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Open-Angle Glaucoma Epidemiology in Japan (2019-2032)
Table 16: Open-Angle Glaucoma Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Open-Angle Glaucoma Epidemiology in 7MM (2019-2032)
Figure 2 Open-Angle Glaucoma Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Open-Angle Glaucoma Epidemiology in the United States (2019-2032)
Figure 4 Open-Angle Glaucoma Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Open-Angle Glaucoma Epidemiology in Germany (2019-2032)
Figure 6 Open-Angle Glaucoma Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Open-Angle Glaucoma Epidemiology in France (2019-2032)
Figure 8 Open-Angle Glaucoma Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Open-Angle Glaucoma Epidemiology in Italy (2019-2032)
Figure 10 Open-Angle Glaucoma Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Open-Angle Glaucoma Epidemiology in Spain (2019-2032)
Figure 12 Open-Angle Glaucoma Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Open-Angle Glaucoma Epidemiology in the United Kingdom (2019-2032)
Figure 14 Open-Angle Glaucoma Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Open-Angle Glaucoma Epidemiology in Japan (2019-2032)
Figure 16 Open-Angle Glaucoma Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report